Big Pharma

Big pharmaceutical companies, despite their vast resources, often struggle to manage special projects outside their core focus areas

Despite their extensive resources and capabilities, the large pharmaceutical companies, often encounter challenges in managing specialized, non-core and core projects that fall outside their primary focus areas. Allypharma can help in such situations and offer its experts’ experience in BD&L, product management, market access and medical affairs. Through this collaboration, the large pharma can maintain their focus on core operations, capitalizing on opportunities while maintaining a strategic flexibility.

  • Scientific and commercial evaluation of specific projects.
  • Support for specific analysis for market insights and forecasting.
  • Support in lifecycle management, including strategies for maximizing the value of mature products.
  • Support for expert reports for different purposes.
  • Review and analysis of strategies to address pricing and reimbursement challenges and insights into payer expectations and evidence generation for value-based pricing.
  • Support of BD evaluation and research teams in identifying and evaluating new opportunities for licensing, acquisition, or partnership. Add an additional resource, with an external view, for a successful deal negotiation.
  • Interim management or specialized expertise to address specific needs for a limited time and/or for a specific project.
Exterior of building